EcoDrugPlus

Coagulation Factor Iiia

Ensembl ID : ENSOTSG00005003494
Gene Symbol: F3A
1 Cross references
191 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSOTSG00005032963
Gene Symbol: F7L
1 Cross references
77 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSOTSG00005032974
Gene Symbol: F7L
1 Cross references
77 Possible Orthologues:

Coiled-Coil Domain-Containing Protein 6-Like

Ensembl ID : ENSOTSG00005026922
Gene Symbol: LOC112253100
3 Cross references
201 Possible Orthologues:

Coiled-Coil Domain-Containing Protein 6-Like

Ensembl ID : ENSOTSG00005018172
Gene Symbol: LOC112255103
3 Cross references
201 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSOTSG00005037335
Gene Symbol: LOC112257809
2 Cross references
301 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSOTSG00005029444
Gene Symbol: LOC112228595
2 Cross references
301 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSOTSG00005019218
Gene Symbol: CSF1R
1 Cross references
57 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSOTSG00005013698
Gene Symbol: CSF1R
3 Cross references
200 Possible Orthologues:

Complement C5

Ensembl ID : ENSOTSG00005000486
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Complement Factor D (Adipsin)

Ensembl ID : ENSOTSG00005013901
Gene Symbol: CFD
1 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSOTSG00005001219
Gene Symbol: CRHR1
1 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).